ArticleBMC plant biology2026
A fungal cell wall elicitor from Neopestalotiopsis clavispora induces systemic defense in Ginkgo Biloba.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSustainable management of tree diseases requires harnessing the plant’s own immune system. Leaf blight caused by Neopestalotiopsis clavispora (N. clavispora) affects the ornamental value of Ginkgo biloba (G. biloba) and the accumulation of its medicinal components. Elicitors, as a novel biological control method, hold potential application value in the prevention and management of G. biloba leaf blight.
resultsWe demonstrate that a cell wall elicitor extracted from the fungal pathogen N. clavispora potently induces systemic resistance against leaf blight in the ancient gymnosperm G. biloba. The elicitor exhibited no direct antifungal activity, confirming that its protective function is mediated exclusively through plant innate immunity. Pre-treatment with the elicitor resulted in over 80% disease control, outperforming commercial resistance inducers and matching the efficacy of carbendazim fungicide. This resistance was associated with a primed state, characterized by a rapid and sustained burst in key defense enzyme activities (POD, PAL, PPO), accelerated accumulation of lignin and phenolics, and mitigated oxidative damage. Metabolomic analyses revealed that the elicitor triggers a change of the defense landscape. We identified coordinated upregulation of the phenylpropanoid pathway, which was directly mirrored by the accumulation of defensive flavonoids and flavonols. Furthermore, tryptophan metabolism and glycerophospholipid pathways were significantly altered, indicating a comprehensive reconfiguration of primary and secondary metabolism.
conclusionsOur findings uncover a multifaceted defense strategy in G. biloba, wherein the fungal elicitor acts as a priming agent to establish a state of alert, enabling a robust, integrated metabolic response that effectively restricts pathogen invasion. This work provides a molecular framework for elicitor-induced resistance in trees and validates a sustainable, vaccine-like strategy for forest protection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.